Invention Grant
![Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide](/docs/US/2019-03-19/US10233142B2/abs.jpg.600x600.jpg)
- Patent Title: Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
-
Application No.: US15836099Application Date: 2017-12-08
-
Publication No.: US10233142B2Publication Date: 2019-03-19
- Inventor: Marlene Michelle Dressman , Deepak Phadke
- Applicant: Vanda Pharmaceuticals, Inc.
- Applicant Address: US DC Washington
- Assignee: Vanda Pharmaceuticals Inc.
- Current Assignee: Vanda Pharmaceuticals Inc.
- Current Assignee Address: US DC Washington
- Agency: Hoffman Warnick LLC
- Main IPC: A61K31/165
- IPC: A61K31/165 ; C07C231/12 ; C07C233/47 ; C07C233/25 ; A61K31/133 ; C07C233/18
![Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide](/abs-image/US/2019/03/19/US10233142B2/abs.jpg.150x150.jpg)
Abstract:
Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-methyl]propanamide, methods for their use, and compositions containing the metabolites.
Public/Granted literature
- US20180099924A1 METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE Public/Granted day:2018-04-12
Information query
